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■ Summary Background High in-
take of vegetables and fruits is as-
sociated with decreased risk of
coronary heart disease. Part of
these cardioprotective effects may
be mediated via the antithrombotic
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effects of compounds found in
vegetables and fruits, such as
flavonoids. Aim of the study To
study the effects of high and low
intake of vegetables, berries and
apple on platelet function and in-
flammatory markers. Methods The
study was a randomised, controlled
parallel human dietary interven-
tion with healthy female and male
volunteers (n = 77, 19–52 y). Nine-
teen healthy volunteers served as
controls. The volunteers consumed
one of four strictly controlled
isocaloric 6-week diets containing
either 810 or 196 g/10 MJ of vegeta-
bles, berries and apple and rich ei-
ther in linoleic acid (11 % of en-
ergy, en%) or oleic acid (12 en%).
Blood and three 24-hour urine
samples were collected at the be-
ginning and at the end of the study
period for analyses of various
markers of platelet function and
inflammation. Results No diffe-
rences between the treatment
groups were seen in platelet count
or volume, markers of platelet acti-
vation (ex vivo aggregation to ADP
and thrombin receptor activating
peptide, protein kinase C activity,
urinary 2,3-dinor-thromboxane B2
excretion, plasma P-selectin),
plasma intercellular adhesion mol-
ecule-1, sensitive C-reactive pro-
tein, or antiphospholipid antibod-
ies. Conclusions The results
indicate that in healthy volunteers
6-week diets differing markedly in
the amounts of vegetables, berries
and apple do not differ in their ef-
fects on platelets or inflammation.
■ Key words vegetables – fruit –
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Introduction
Based on epidemiological data, diets rich in vegetables
and fruit are considered to prevent coronary heart dis-
ease [1]. These effects have often been explained by the
antioxidant effects of plant compounds. However, it is
plausible that also other mechanisms, e. g. antithrom-
botic or anti-inflammatory effects, are involved.
Platelets play a crucial role in thrombosis but are also
involved in atherogenesis. The effects of dietary fatty
acids on platelet function have been studied actively [2]
but much less information is available on the effects of
other dietary constituents. Vegetables and fruit contain
several molecules which could affect platelets. Platelet
activation is modulated by oxygen free radicals [3], and
there is evidence that antioxidant vitamins could de-
crease platelet function in humans [4–6]. The possible
antithrombotic effects of flavonoids have been of large
interest lately because they inhibit platelet function by
several mechanisms in vitro [7–9]. Endothelial function
and inflammation are firmly associated with atheroscle-
rosis and thrombosis [10–12] and may be affected by di-
etary components [13–15].Other factors associated with
the risk of thrombosis are antiphospholipid antibodies
[16–18] which have been reported to be associated with
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Vegetables and fruit are a rich source of several nu-
trients and other possible active compounds and their
beneficial effects are hardly explained by single compo-
nents. Furthermore, part of the health promoting effects
of vegetables and fruit may be due to their low content
of energy and saturated fat. Some studies even suggest
that their intake may be merely a marker of an otherwise
healthful behaviour [20]. Controlled intervention stud-
ies on the effects of vegetables and fruit are thus clearly
needed.We have carried out a strictly controlled dietary
intervention with healthy volunteers to study how diets
which differ markedly in the amounts of vegetables and
fruit affect several markers associated with atheroscle-
rosis or thrombosis [21]. In the present paper we report
the results related to platelets and inflammation.
Subjects and methods
The dietary intervention was carried out in a strictly
controlled way at the Division of Nutrition,University of
Helsinki. The study design has been published previ-
ously [21]. The Ethics Committee of the Faculty of Agri-
culture and Forestry of the University of Helsinki
approved the study protocol. All subjects gave their in-
formed consent before the study.
■ Subjects
Healthy human volunteers were recruited among stu-
dents and employees from the Viikki campus of the Uni-
versity of Helsinki. Eighty healthy volunteers started the
study but three female subjects dropped out because of
personal reasons. Four of the volunteers were regular
smokers and oral contraceptives were used by 51 % of
the female subjects evenly distributed between the
groups. Nineteen healthy subjects who kept their habit-
ual diet constant (checked by dietary records) served as
controls. The baseline characteristics of the subjects are
shown in Table 1. Habitual diet of the subjects was
checked before the intervention by 3-d food records and
was found adequate. Furthermore, the treatment groups
did not differ in this respect [21].
■ Study design and diets
The study was a parallel intervention. The volunteers
were assigned to four treatment groups to have one of
the four experimental diets for 6 weeks.The subjects had
lunch every weekday at the Division of Nutrition. After
lunch they took food for the rest of the day and for the
next morning and on Fridays for the whole weekend
with them. The experimental foods provided 90 % of the
daily energy (en%) and the subjects had to choose the
other 10 en% from a limited list of foods free of fat and
cholesterol and low in antioxidants (sweets, sugar, grain
products, limited amount of alcoholic beverages exclud-
ing red wine and berry wines, soft drinks, and selected
vegetables/fruit).The study foods were weighed for each
subject according to the energy needs (menus 7–16
MJ/d) and the amount of food was adjusted if there were
changes in body weight (monitored twice a week).
The experimental diets consisted of normal foods
and were either poor (diets P1 and M1) or rich (diets P2
and M2) in vegetables, berries and apple, and either rich
in linoleic acid (11 en%; diets P1 and P2) or oleic acid (12
en%; diets M1 and M2) (Table 2). Energy intakes in the
low-vegetable diets were adjusted by sugar and starch.
The intakes of total (33 en%) and saturated fat (10 en%),
n-3 fatty acids (0.4 en%),protein (13 en%),and total car-
bohydrates (54 en%, including fiber) were similar in all
diets. Major differences between the nutrient intakes
Table 1 Baseline characteristics of the subjects and mean dietary energy intake levels during the experimental diets. Values are mean (range or SD)
Treatment group Difference
between groupsb
Variable P1a P2 M1 M2 Control group
n = 18 n = 20 n = 20 n = 19 n = 19
Females/males (n) 13/5 15/5 15/5 14/5 15/4
Age (y) 25.4 (19–38) 26.2 (19–50) 25.5 (20–52) 23.3 (19–37) 0.584 32.7 (22–50)
BMI (kg/m2) 22.1 (18.5–33.6) 23.1 (18.6–33.7) 22.9 (19.1–29.9) 22.1 (17.9–25.9) 0.738 23.2 (19.0–28.9)
Total cholesterol (mmol/L) 4.30 (0.49)c 4.76 (0.81)c, d 4.92 (0.83)d 4.37 (0.66)c, d 0.012 4.91 (0.71)
Total triacylglycerols (mmol/L) 0.86 (0.26) 0.98 (0.39) 1.01 (0.34) 0.95 (0.39) 0.610 1.01 (0.47)
Energy level (MJ/d)e 9.8 (1.4) 10.0 (2.0) 10.7 (2.3) 10.0 (1.7) 0.528 –
a The treatment groups are named according to the experimental diets: P1 rich in linoleic acid and low in vegetables; P2 rich in linoleic acid and high in vegetables, berries
and apple; M1 rich in oleic acid and low in vegetables; and M2 rich in oleic acid and high in vegetables, berries and apple
b The p-value of the difference between the treatment groups (one-way ANOVA or Kruskall-Wallis one-way analysis of variance)
c, d Groups with different superscript letters differ significantly (p < 0.05, post-hoc analysis of Tukey)
e Mean energy intake level during the experimental period (fiber is included in the total energy)
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were in antioxidants and unsaturated fatty acids (Table
2). According to earlier studies, the effects of high in-
takes of linoleic and oleic acids on platelets do not differ
[22–24] but the fatty acid modifications were interesting
in respect of other markers [21].
The subjects kept their normal lifestyle during the
experimental period. The control subjects kept their ha-
bitual diet (checked by repeated dietary records) but
gave the same blood and urine samples as the study sub-
jects.
■ Compliance with the diets
Compliance with the experimental diets was good ac-
cording to study diaries and biochemical markers [21,
25]. Plasma vitamin C and β-carotene increased in the
high-vegetable groups (P2: + 2.6 and + 0.6 µmol/L;
M2: + 3.0 and + 0.5 µmol/L, respectively) while the re-
spective concentrations in the low-vegetable groups did
not change (P1: –0.1 and + 0.1 µmol/L; M1: + 0.2 and
0.1 µmol/L). Also other carotenoids and plasma
quercetin increased in the high-vegetable groups in
comparison with low-vegetable groups [21]. Further-
more, the high- and low-vegetable groups differed in
urinary excretions of several flavonoids [25]. Alpha-to-
copherol slightly increased in the groups P1 and P2
(+ 0.5 µmol/mmol lipids in both groups) in comparison
with groups M1 and M2 (–0.1 µmol/mmol lipids in both
groups). Plasma fatty acids reflected diet fatty acid com-
positions. No differences between the experimental di-
ets in lipoprotein metabolism or markers of lipid perox-
idation were seen [21].
■ Laboratory methods
Blood samples were taken before and at the end of the
dietary period. The samples were taken by trained labo-
ratory nurses from the antecubital vein with minimal
stasis after overnight fasting. Vacuum tubes were used
(Venoject and Venoject II, Terumo Europe, Leuven, Bel-
gium; Vacuette, Greiner Labortechnic, Kremsmünster,
Austria). The laboratory staff were blinded for the treat-
ments and study groups of the subjects.
Blood cells were calculated from EDTA and citrated
blood 30 min after sampling with CellDyn 1600 cell
counter (Abbott Laboratories, USA) using calibration
plasma PAR12 (Streck Laboratories, NB). Citrated blood
was used for platelet mean cell volume measurements
because platelets may swell in EDTA-blood. For platelet
aggregation studies, platelet rich plasma (PRP) was sep-
arated from citrated blood by centrifugation (110  g for
10 min at room temperature) and platelet poor plasma
(PPP) by further centrifugation (2000  g, 10 min, room
temperature). Platelet count in PRP was adjusted to
250 109/L with PPP. Platelet aggregation response to
ADP (final concentrations 1 and 2.5 µmol/L; Boehringer
Mannheim, Germany) and thrombin receptor activating
peptide SFLLRN (TRAP) (5 and 10 µmol/L; Bachem,
Bubendorf, Switzerland) was measured turbidometri-
cally (IIPA-3220-aggregometer, Kyoto Daichi Kagaku
Co, Ltd., Japan) within 90 minutes from blood sampling
by adding 50 µL of aggregating agent in 450 µL pre-
warmed (37 °C) PRP (stirring rate 900 rpm). The maxi-
mal velocity (%/min) and maximal aggregation (%)
were recorded.
Protein kinase C (PKC) is one of the central cell-sig-
nalling enzymes in platelets. For PKC activity assays
blood was drawn in buffered sodium citrate and sam-
ples prepared as described [23]. PKC activity was
analysed from the cytosolic and membrane fractions by
Biotrak RPN 77 assay (Amersham, Little Chalfont, UK)
and standardized by protein concentrations (Bradford
reagent, Bio-Rad, CA).
Citrate blood samples from groups P1 (n = 12) and
Table 2 The calculated fatty acid compositions and intakes of some antioxidants
and certain foods in the experimental diets
Experimental diet
Nutrient/food P1a P2 M1 M2
Total SFAb (en%)c 10.4 10.0 10.4 10.0
Total MUFA (en%) 8.0 7.8 15.8 15.7
Oleic acid (18:1 n-9) (en%) 4.5 4.5 12.3 12.3
Total PUFA (en%) 10.9 11.1 3.1 3.2
Linoleic acid (18:2 n-6) (en%) 10.0 10.1 2.1 2.2
P/S ratio 1.0 1.1 0.3 0.3
Vitamin C (mg/10 MJ) 105 333 105 333
Total carotenoids (mg/10 MJ) 5.2 16.9 5.2 16.9
β-carotene (mg/10 MJ) 3.0 10.1 3.0 10.1
Vitamin E (mg TE/10 MJ) 28 32 8 12
Vitamin E/PUFA (mg TE/g) 1.0 1.1 1.0 1.4
Quercetin (mg/10 MJ) 2.6 24.1 2.6 24.1
Folate (µg/10 MJ) 295 421 295 421
Fresh or frozen vegetablesd (g/10 MJ) 167 440 167 440
Fresh fruitse (g/10 MJ) 54 166 54 166
Frozen berriesf (g/10 MJ) 0 204 0 204
a The experimental groups were on following diets: P1 rich in linoleic acid and low
in vegetables; P2 rich in linoleic acid and high in vegetables, berries and apple; M1
rich in oleic acid and low in vegetables; and M2 rich in oleic acid and high in veg-
etables, berries and apple
b SFA saturated fatty acids; MUFA monounsaturated fatty acids; PUFA polyunsatu-
rated fatty acids
c en% % of total energy
d Most abudant vegetables in the diets P2 and M2 were: carrot, tomato, cabbage,
cucumber, broccoli, onion, and french beans. In diets P1 and M1: carrot, cabbage,
cucumber, chinese cabbage and tomato
e Fruits in the diets P2 and M2 were mainly unpeeled apple; in diets P1 and M1 ba-
nana and peeled apple
f Most abudant berries in diets P2 and M2 were: strawberry, raspberry, bilberry,
black currant and lingonberry
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M2 (n = 13) were delivered immediately after sampling
to the Platelet Laboratory of the Finnish Red Cross
Blood Transfusion Service. Dual-colour staining of
blood samples with fluorochrome-labelled monoclonal
antibodies [fluorescein isothiosyanate labelled anti-
CD41 (Biodesign, Kennebunk, ME) and phycoerythrin
labelled anti-CD62P (CLB, Netherlands)] was per-
formed for 15 min at + 37 °C in the dark. Simultest TM
Control g1/g1 (IgG1/IgG1) (Becton Dickinson, San Jose,
CA) was employed to detect nonspecific antibody bind-
ing. After incubation, 1 mL of FACSFlow fluid (Becton
Dickinson) was added to each tube for flow cytometry
(FACScan, Becton Dickinson). 500 000 events were ac-
quired and analysed using CellQuest TM software (Bec-
ton Dickinson). Analysis was performed on gated
platelet populations identified by characteristic forward
and 90° light scatter properties. The percentage of
platelets expressing CD62P was defined as the percen-
tage of positive cells compared with the controls.
Plasma soluble P-selectin and intercellular adhesion
molecule-1 (ICAM-1) were analysed from lithium he-
parin plasma with ELISA kits (BBE6 and BBE1B, R&D
Systems, Abingdon, UK). Serum sensitive C-reactive
protein (CRP), and antibodies to oxidized LDL, anticar-
diolipin and prothrombin were analyzed by ELISA as-
says as described elsewhere [16–18].
All subjects collected three consecutive 24-hour
urine samples before and at the end of the experimental
period using urine collecting aliquot cups (Daisho co.
Ltd, Osaka, Japan) with ascorbic acid as a preservative.
Aliquots were stored at –20 °C. For analysis of the uri-
nary metabolite of thromboxane A2, 2,3-dinor-throm-
boxane B2 (2,3-dinor-TXB2), the three samples were
pooled as a 72-hour sample and analyzed enzymoim-
munologically as reported [26] using commercial
reagents (Cayman Chemicals, Ann Arbor, MI). Urinary
creatinine was measured by a colourimetric method
(Merckotest #3384, Merck Diagnostica, Darmstadt, Ger-
many).
■ Statistics
All statistical analyses were carried out with the Systat
statistical software package (Systat 5.2, SYSTAT Inc,
Evanston, IL). Normality of the data was tested by the
Lilliefors test and logarithmic transformations were
used when necessary. Non-parametric tests were used if
logarithmic data were not normally distributed.
Possible differences between the pre-experimental
levels in the treatment groups were compared by one-
way ANOVA and post hoc test of Tukey or Kruskal-Wal-
lis one way analysis of variance and Mann-Whitney U-
test with Bonferroni correction. The treatment effect
was calculated as the difference between experimental
and pre-experimental values within the groups. The
treatment effects of the study groups were compared by
one-way ANOVA and post hoc test of Tukey or Kruskal-
Wallis one-way analysis of variance and Mann-Whitney
U-test with Bonferroni correction. Differences between
pre-experimental and experimental values within the
treatment groups were tested by paired t-test or
Wilcoxon signed ranks test. In all analyses, results with
p < 0.05 were considered significant.
Results
The results are shown in Table 3.Platelet count increased
in the group P1 but no differences between the treat-
ment groups were seen in platelet count or volume
(Table 3). In other blood cell indices no effects between
or within groups were seen (data not shown). Because
the platelet aggregation results were parallel with ADP 1
and 2.5 µmol/L; responses to TRAP 5 µmol/L were weak;
and the slope of the aggregation curve and maximal ag-
gregation gave parallel results with both agonists, only
maximal aggregation from the higher concentrations of
ADP (2.5 µmol/L) and TRAP (10 µmol/L) are shown in
Table 3. Aggregation responses to ADP and TRAP
tended to increase in all treatment groups without dif-
ferences between groups.
Urinary 2,3-dinor-TXB2 tended to decrease in the
groups P1 and P2 but, possibly due to the large in-
terindividual variation,no significant differences within
or between the treatments were seen (Table 3). Mean
PKC activities were not differently affected by the diets
although PKC activity in the membrane fraction de-
creased in the group P2. Platelet activation was mea-
sured by flow cytometry in subsamples of groups P1 and
M2. In the group P1 the proportion of activated cells
[mean (SD)] was before the study 2.16 % (3.78) and at
the end of the experimental period 3.25 % (6.85). The re-
spective proportions in the group M2 were 2.56 (3.52)
and 2.07 % (2.21). Statistical analysis showed no diffe-
rences between the groups.
Plasma soluble P-selectin was not affected by the
treatments (Table 3). Soluble ICAM-1 slightly increased
in the group M1 but there were no significant differences
between the diets. Serum sensitive CRP decreased in the
group P1 without significant differences between
groups. The pre-experimental levels of serum anticardi-
olipid antibodies tended to be low in the groups P1 and
P2 and increased during the experimental period but
there were no differences between the treatment effects
in any of the antiphospholipid antibodies (Table 3). The
results of the control group showed no differences be-
tween the pre-experimental and experimental values in
any variable which indicates absence of period effect in
the results (Table 3).
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Discussion
Our aim was to find out whether isocaloric diets with
large or small amounts of vegetables, berries and apple
affect various markers associated with the risk of coro-
nary heart disease differently. Compliance with the ex-
perimental diets was verified by biomarkers [21,25].The
present results show that none of the experimental diets
could markedly modify the markers of platelet activa-
tion or inflammation in our healthy volunteers.
Vegetables, berries and apple are rich sources of
flavonoids.There is much data indicating that flavonoids
could modulate platelet activation and function by sev-
eral mechanisms at least in vitro. Usually in concentra-
tions higher than nutritionally achievable, flavonoids
have been shown e.g. to inhibit platelet aggregation [7,9,
27] and alter pathways involved in platelet activation
such as cyclic AMP levels, arachidonic acid metabolism,
phospholipase C pathway and nitric oxide production [8,
9, 28–30]. Enzyme inhibiting effects presumably require
intracellular presence but flavonoids can also affect
platelet function without entering the platelet e.g. via
thromboxane receptor antagonism [8].
Table 3 Platelet indices, soluble intercellular adhesion molecule-1, C-reactive protein and antiphospholipid antibodies in pre-experimental period and the change during
the experimental period. The values are mean (SD)
Treatment group Difference
Variable Perioda between groupsc
P1b P2 M1 M2 Control group
n = 18 n = 20 n = 20 n = 19 n = 19
Platelet count (109/L) PRE 244 (45) 243 (39) 252 (42) 253 (51) 255 (52)
Change 12 (24)d –2 (28) –10 (30) –6 (40) 0.149 –6 (29)
Mean platelet volume (fl) PRE 7.46 (0.89) 7.18 (0.83) 7.30 (0.98) 7.39 (0.91) 7.19 (1.02)
Change –0.18 (0.51) 0.04 (0.31) 0.07 (0.44) 0.16 (0.44) 0.119 0.22 (0.67)
Aggregation to ADP PRE 55.8 (21.5) 43.6 (22.5) 42.8 (24.1) 48.2 (22.7) 44.6 (27.2)
2.5 µmol/L (%) Change 9.6 (13.6)d 13.3 (24.0)d 20.9 (22.2)d 9.6 (14.8)d 0.244 9.0 (21.1)
Aggregation to TRAP PRE 43.1 (28.3) 31.7 (24.4) 25.2 (22.9) 41.9 (30.4) 30.5 (31.3)
10 µmol/L (%) Change 7.2 (17.3)d 14.7 (27.6)d 27.9 (31.4)d 2.0 (27.5) 0.126 4.2 (25.2)
Urinary 2,3-dinor-TXB2 PRE 995 (547) 896 (815) 871 (648) 847 (345) 622 (265)
(pg/mg crea) Change –206 (550) –170 (773) –72 (575) –59 (401) 0.849 11 (209)
n = 12 n = 15 n = 17 n = 13 n = 15
Cytosolic PKC activity PRE 1785 (570) 1755 (491) 1634 (609) 1724 (432) 1931 (400)
(pmol/min/mg prot) Change 170 (643) 161 (752) 173 (905) 96 (376) 0.991 415 (894)
Membrane PKC activity PRE 1485 (1045) 1628 (841) 1489 (902) 1476 (705) 1259 (553)
(pmol/min/mg prot) Change –74 (500) –238 (496)d –229 (743) 4 (597) 0.651 38 (636)
n = 18 n = 20 n = 20 n = 19 n = 19
Plasma P-selectin (ng/mL) PRE 50.6 (17.7) 48.1 (13.8) 52.6 (16.2) 48.3 (15.6) 71.7 (50.4)
Change 0.2 (6.2) –0.8 (6.0) 0.8 (4.3) –0.2 (5.0) 0.819 –16.8 (47.9)
Plasma ICAM-1 (ng/mL) PRE 203.3 (55.9) 212.7 (83.4) 223.5 (59.0) 215.3 (69.4) 211.4 (33.1)
Change –2.2 (26.7) –1.0 (38.9) 15.0 (27.2)d 1.6 (31.2) 0.318 –3.8 (25.1)
Serum CRP (µg/mL) PRE 3.11 (4.79) 2.61 (4.07) 6.41 (13.88) 3.61 (5.03) 3.11 (8.34)
Change –2.00 (4.74)d 1.27 (7.21) –4.18 (12.98) –1.92 (5.04) 0.264 –1.80 (8.14)
Ox-LDL Ab (OD) PRE 0.112 (0.052) 0.142 (0.080) 0.112 (0.051) 0.140 (0.060) 0.083 (0.053)
Change 0.004 (0.041) 0.006 (0.034) 0.001 (0.031) –0.003(0.027) 0.668 –0.001(0.023)
Anticardiolipin Ab (OD) PRE 0.045 (0.017) 0.043 (0.015) 0.070(0.045) 0.086 (0.065) 0.033 (0.016)
Change 0.006 (0.010)d 0.009 (0.013)d 0.005 (0.024) 0.019 (0.065) 0.415 0.006 (0.014)
Prothrombin Ab (OD) PRE 0.144 (0.048) 0.148 (0.042) 0.142 (0.053) 0.181 (0.155) 0.125 (0.120)
Change 0.009 (0.051) 0.006 (0.037) 0.005 (0.038) 0.008 (0.043) 0.962 0.045 (0.125)
a PRE pre-experimental period; Change EXP-PRE (EXP = experimental period)
b The treatment groups are named according to the experimental diets: P1 rich in linoleic acid and low in vegetables; P2 rich in linoleic acid and high in vegetables, berries
and apple; M1 rich in oleic acid and low in vegetables; and M2 rich in oleic acid and high in vegetables, berries and apple
c p-value of difference between the treatment effects in the dietary groups. The data was tested by comparing the changes by one-way analysis of variance or by Kruskall-
Wallis one-way analysis of variance
d Significant difference between PRE and EXP values within the treatment group (p < 0.05, paired t-test or Wilcoxon signed ranks test)
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Despite several possible mechanisms, platelet effects
have rarely been shown in controlled human interven-
tions with foods or beverages rich in flavonoids. Platelet
aggregation has not been modified by onion and parsley
supplementation [7], black tea [31, 32] or sea buckthorn
juice ingestion [33]. Furthermore, the diminuation in
platelet aggregation after red wine exposure seems to be
due to ethanol rather than red wine phenolics [34, 35].
Green tea extract supplementation has also been shown
ineffective with respect to urinary 2,3-dinor-TXB2 [36].
In the present study, the calculated flavonoid intakes in
the high-vegetable diets compared with the low-
vegetable diets were as high as 10-fold. However, no dif-
ferences in platelet indices were seen. Quercetin concen-
trations in fasting plasma significantly increased in the
high-vegetable groups during the experimental period
but the average levels did not exceed 140 nmol/L [21]. It
seems plausible that the bioavailability of most dietary
flavonoids is too low to result in platelet effects in vivo at
least in fasting conditions. The acute effects of
flavonoids have been less studied. There are, however,
studies which show decreased platelet aggregation after
ingestion of red grape juice [37] and decreased flow-cy-
tometrically measured platelet activation after cocoa in-
gestion [38]. In both studies, platelet aggregability did
not decrease after other flavonoid-rich beverages. The
fact that we did not detect any platelet effects by high-
vegetable diets does not exclude the possibility that con-
centrated sources of specific flavonoids can have post-
prandial platelet effects. The biological significance of
such short-term effects in the prevention of CHD re-
mains, however, to be proven.
In the present setting, we also modified the volun-
teers’ intakes of carotenoids as well as vitamin C and
vitamin E. Sea buckthorn juice which is rich not only in
flavonoids but also in vitamin C and carotenoids,did not
affect platelet ex vivo aggregability when drunk for 8
weeks [33]. However, supplementation studies have
shown that pharmacological doses of a mixture of vita-
min C, vitamin E and β-carotene or vitamin E alone de-
crease platelet aggregation to ADP especially if the base-
line vitamin status is poor [4,5].Vitamin C or β-carotene
supplementation alone have shown no effects [5]. In ad-
dition to α-tocopherol, other tocopherols also seem to
have anti-platelet effects [39]. Tocopherols decrease
platelet activation via PKC inhibition [6, 39] but also ni-
tric oxide release and superoxide dismutase amount
have been reported to be modulated by tocopherol sup-
plementation [39]. In the present study,the amount of α-
tocopherol was higher in the high-linoleic acid diets
than in the high-oleic acid diets which was also reflected
in plasma α-tocopherol concentrations [21]. The diffe-
rences in α-tocopherol concentrations were probably far
too modest to affect platelet function.
P-selectin is an adhesion molecule which mediates
leucocyte rolling on endothelium. It is expressed by ac-
tivated endothelial cells and platelets, and its plasma
concentrations can be used as an in vivo marker of the
activation of these cells [40, 41]. Soluble P-selectin has
been shown to be associated with the risk of future car-
diovascular events in women [42]. Our results indicate
that soluble P-selectin is not easily affected by dietary
means. However, Hodgson et al. [32] reported a decrease
in plasma P-selectin concentration by black tea inges-
tion.
In the present study, P-selectin positive platelets were
also measured as a marker of platelet activation status in
vivo. The subgroup of volunteers for these flow-cyto-
metrical analyses was picked up from the low-vegetable
high-linoleic acid group P1 and the high-vegetable high-
oleic acid group M2. The average activation levels were
low in our healthy subjects and, although there was a
tendency towards enhanced activity in the group P1 and
decreased activity in the group M2, no differences be-
tween the diets could be statistically detected. Cocoa in-
gestion has been reported to decrease the numbers of P-
selectin positive platelets in a postprandial study [38].
ICAM-1 is an another endothelial adhesion molecule
which mediates the adhesion of leucocytes on the en-
dothelial surface. Soluble ICAM-1 has been strongly as-
sociated with the risk of ischemic heart disease [10].An-
tioxidants could affect ICAM-1 because its expression is
mediated via the transcription factor nuclear factor-κB
which is stimulated by cellular oxidative stress [43]. We
saw no differences in ICAM-1 between the high vs. low
vegetable groups. Neither black tea nor sea buckthorn
juice have affected soluble ICAM-1 in earlier studies [32,
33].
The acute phase protein CRP has been recognised as
a powerful predictor of cardiovascular risk [10]. In the
present study, the dietary factors did not cause changes
in the concentration of CRP. Earlier data on dietary ef-
fects on CRP is scarce but in one study it was not affected
by black or green tea consumption [44]. We measured
also serum antiphospholipid antibodies which have
been shown to be associated with increased risk of coro-
nary events in case-control studies [16–18]. There is in-
direct evidence that diet could modify antiphospholipid
antibody formation in oxidative stress. In male cigarette
smokers plasma vitamin C, but not vitamin E or β-
carotene, was inversely associated with antibodies to
cardiolipin and oxidized LDL [45]. Furthermore, in dia-
betic patients high levels of antibodies to oxidized LDL
were associated with high proportion of polyunsatu-
rated fatty acids in LDL [46]. The antibody levels were
low in our healthy volunteers and no differences be-
tween the groups were seen. Our finding is in concor-
dance with that of O’Reilly et al. [47] who found no
changes in antibodies to oxidized LDL in healthy volun-
teers consuming large amounts of tea and onions. It is
possible that the effect of dietary factors on the produc-
tion of antiphospholipid antibodies could be detectable
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only in subjects with increased antibody levels due to an
underlying pro-oxidative stimulus,such as smoking and
stress.
Conclusions
In this highly controlled human intervention study diets
rich or poor in vegetables, berries and apple did not dif-
fer in their effects on the wide range of markers related
to platelet and endothelial function and inflammation.
The overall conclusion of the present study is that in
healthy volunteers with adequate habitual diet, only
marginal effects on markers associated with platelets or
inflammation can be achieved by modulating the in-
takes of vegetables and fruit or unsaturated fatty acids.
The present results do not indicate that platelet function
or inflammation are the processes in the pathophysiol-
ogy of CHD favourably affected by diets high in vegeta-
bles and fruits. However, our results do not exclude the
possibility that in different populations e. g. among
heavy smokers or subjects with marginal antioxidant in-
take, diets comparable to ours could have different ef-
fects.
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